243 related articles for article (PubMed ID: 20562782)
1. Suicide risk and choice of antidepressant.
Davis A; Gilhooley M; Agius M; Zaman R
Psychiatr Danub; 2010 Jun; 22(2):358-9. PubMed ID: 20562782
[TBL] [Abstract][Full Text] [Related]
2. An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Agius M; Gardner J; Liu K; Zaman R
Psychiatr Danub; 2010 Jun; 22(2):346-9. PubMed ID: 20562779
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.
Mines D; Hill D; Yu H; Novelli L
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):367-72. PubMed ID: 15883980
[TBL] [Abstract][Full Text] [Related]
4. An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
Agius M; Gardner J; Liu K; Zaman R
Psychiatr Danub; 2010 Jun; 22(2):350-3. PubMed ID: 20562780
[TBL] [Abstract][Full Text] [Related]
5. Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Perlis RH; Uher R; Perroud N; Fava M
J Clin Psychiatry; 2012 Nov; 73(11):1439-42. PubMed ID: 23059018
[TBL] [Abstract][Full Text] [Related]
6. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database.
Khan A; Khan SR; Leventhal RM; Brown WA
Int J Neuropsychopharmacol; 2001 Jun; 4(2):113-8. PubMed ID: 11466159
[TBL] [Abstract][Full Text] [Related]
7. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study.
Rubino A; Roskell N; Tennis P; Mines D; Weich S; Andrews E
BMJ; 2007 Feb; 334(7587):242. PubMed ID: 17164297
[TBL] [Abstract][Full Text] [Related]
8. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
9. Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.
Agius M; Gardner J; Liu K; Zaman R
Psychiatr Danub; 2010 Nov; 22 Suppl 1():S46-8. PubMed ID: 21057402
[TBL] [Abstract][Full Text] [Related]
10. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
Brent DA; Emslie GJ; Clarke GN; Asarnow J; Spirito A; Ritz L; Vitiello B; Iyengar S; Birmaher B; Ryan ND; Zelazny J; Onorato M; Kennard B; Mayes TL; Debar LL; McCracken JT; Strober M; Suddath R; Leonard H; Porta G; Keller MB
Am J Psychiatry; 2009 Apr; 166(4):418-26. PubMed ID: 19223438
[TBL] [Abstract][Full Text] [Related]
11. Erotomania induced by venlafaxine: a case study.
Adamou M; Hale AS
Acta Psychiatr Scand; 2003 Apr; 107(4):314-7. PubMed ID: 12662255
[TBL] [Abstract][Full Text] [Related]
12. Less mood switching with venlafaxine?
Mattes JA
Am J Psychiatry; 2006 Sep; 163(9):1642; author reply 1642-3. PubMed ID: 16946194
[No Abstract] [Full Text] [Related]
13. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
Vieta E; Martinez-Arán A; Goikolea JM; Torrent C; Colom F; Benabarre A; Reinares M
J Clin Psychiatry; 2002 Jun; 63(6):508-12. PubMed ID: 12088162
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine: a novel antidepressant.
Keltner NL
J Psychosoc Nurs Ment Health Serv; 1995 Jan; 33(1):51-3. PubMed ID: 7738872
[TBL] [Abstract][Full Text] [Related]
15. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
Post RM; Altshuler LL; Leverich GS; Frye MA; Nolen WA; Kupka RW; Suppes T; McElroy S; Keck PE; Denicoff KD; Grunze H; Walden J; Kitchen CM; Mintz J
Br J Psychiatry; 2006 Aug; 189():124-31. PubMed ID: 16880481
[TBL] [Abstract][Full Text] [Related]
16. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Lenox-Smith AJ; Jiang Q
Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode.
Amsterdam J
J Clin Psychopharmacol; 1998 Oct; 18(5):414-7. PubMed ID: 9790160
[TBL] [Abstract][Full Text] [Related]
18. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
Brent DA
Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
[No Abstract] [Full Text] [Related]
19. [Trazodone and venlafaxine in treatment of depressive disorders].
Florkowski A; Gruszczyński W; Gałecki P; Zboralski K; Kołodziejska I; Mikołajczyk I
Pol Merkur Lekarski; 2005 May; 18(107):556-9. PubMed ID: 16161955
[TBL] [Abstract][Full Text] [Related]
20. Prescribing of venlafaxine and dosulepin in primary care.
McAllister-Williams RH; Foran K; Forrest S; Ingram G; McMahon L; Taylor M; Rajwal MS; Cornwall PL
J Psychopharmacol; 2006 Nov; 20(6):868. PubMed ID: 17060347
[No Abstract] [Full Text] [Related]
[Next] [New Search]
